Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FOLFOX-Based Transarterial Infusion Chemotherapy for Locally Advanced Gastric Cancer and Gastroesophageal Junction Adenocarcinoma: Protocol of an Open-Label, Multicentre, Single-arm, Phase Ⅱ Trial

NCT07655024 is registered in ClinicalTrials.gov with Guang'anmen Hospital of China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT07655024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07655024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FOLFOX-Based Transarterial Infusion Chemotherapy for Locally Advanced Gastric Cancer and Gastroesophageal Junction Adenocarcinoma: Protocol of an Open-Label, Multicentre, Single-arm, Phase Ⅱ Trial
Lead sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase
Phase 2
Overall status
Recruiting
Start date
November 1, 2025
Completion date
December 1, 2028
Enrollment
31 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer (diagnosis), gastroesophageal junction adenocarcinoma